AN
41
-3
FE
39
-2
APD
37
-3
BWA
40
-4
INTC
45
4
DGX
29
-4
CFG
46
-2
VZ
27
-2
RCL
76
7
WMT
76
-6
SYF
88
-2
EMR
48
-3
V
62
-4
FLR
43
3
BXP
44
-3
GLW
61
-2
EMN
66
-6
UPS
40
-8
LRCX
77
6
CVS
49
-3
AN
41
-3
FE
39
-2
APD
37
-3
BWA
40
-4
INTC
45
4
DGX
29
-4
CFG
46
-2
VZ
27
-2
RCL
76
7
WMT
76
-6
SYF
88
-2
EMR
48
-3
V
62
-4
FLR
43
3
BXP
44
-3
GLW
61
-2
EMN
66
-6
UPS
40
-8
LRCX
77
6
CVS
49
-3
Financhill
Back

Mereo BioPharma Group PLC 10K Form

Buy
55

MREO
Mereo BioPharma Group PLC

Last Price:
3.50
Seasonality Move:
-1.43%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive MREO News And Ratings

See the #1 stock for the next 7 days that we like better than MREO

MREO Financial Statistics

Sales & Book Value

Annual Sales: $10M
Cash Flow: $-8.69M
Price / Cash Flow: 0
Annual Sales: $0.31
Price / Book: 12.48

Profitability

Net Income (TTM): $0
Gross Margin: $7.43M
Return on Equity: 0%
Return on Assets: 0%

Mereo BioPharma Group PLC Earnings Forecast

Key Mereo BioPharma Group PLC Financial Ratios

  • The Gross Profit Margin over the past 7 years for MREO is 74.26%.
  • The Selling, General & Administrative Expenses for MREO have been equal to 184.24% of Gross Profit Margin.
  • The Research & Development expenses have been 174.18% of Revenue.
  • The Interest Expense is -9.78% of Operating Income.
  • The Net Earning history of MREO is -294.66% of Total Revenues.
  • Per Share Earnings over the last 8 years have been positive in 5 years.

Mereo BioPharma Group PLC Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Biotechnology
Sector: Health Care
Current Symbol: MREO
CUSIP: 589492
Website: mereobiopharma.com

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 0
Quick Ratio: 0

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

MREO Technical Analysis vs Fundamental Analysis

Buy
55
Mereo BioPharma Group PLC (MREO) is a Buy

Is Mereo BioPharma Group PLC a Buy or a Sell?